FDA Approves New Indication for SimponiFDA Approves New Indication for Simponi

The agency has approved golimumab (Simponi) injection to treat adults with moderate to severe refractory ulcerative colitis. FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news